Swedish Orphan Biovitrum

Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Mon, 09/30/19 - 12:06 pm
Dova Pharmaceuticals
Eisai
Swedish Orphan Biovitrum
M&A
Swedish Orphan Plunges After Talks End on Potential Takeover
Bloomberg
Mon, 06/8/15 - 11:24 am
M&A
Swedish Orphan Biovitrum
Sobi
Pfizer emerges as mystery bidder for rare disease firm Swedish Orphan
BioPharma Dive
Fri, 05/1/15 - 10:17 am
Pfizer
M&A
Swedish Orphan Biovitrum
Sobi
Biogen partner Sobi and its Boston-based CEO field a takeover bid
Fierce Biotech
Mon, 04/27/15 - 09:41 am
Sobi
Swedish Orphan Biovitrum
Biogen
M&A
Swedish Orphan Said to Be Open to Sale Amid Boom in Drug Deals
Bloomberg
Sun, 04/26/15 - 09:23 am
Swedish Orphan Biovitrum
M&A
Pfizer
Biogen
Biogen, Sobi pledge hemophilia drug donation in developing world
Yahoo/Reuters
Mon, 05/12/14 - 08:21 am
Biogen Idec
hemophilia
Swedish Orphan Biovitrum